This content is machine translated Guideline recommendations 2022 Update on secondary prevention of ischemic stroke and TIA. This year, the German Society of Neurology (DGN) and the German Stroke Society (DSG) published the new S2k guideline ‘Secondary prevention of ischemic stroke and transient ischemic attack’. This contains…
View Post 3 min This content is machine translated Antiplatelet agents Ticagrelor reduces risk of recurrent stroke After an acute cerebral infarction or a transient ischemic attack (TIA), the risk of another stroke is massively increased. That early treatment with an antiplatelet agent contributes to secondary prevention…
View Post 3 min This content is machine translated Stroke recurrence after TIA or minor stroke Use the possibilities of secondary prophylaxis Purpose: To evaluate the 1-year risk of stroke recurrence after TIA or minor stroke under a modern secondary prevention regimen.
View Post 4 min This content is machine translated Interdisciplinary Symposium Neuro Emergencies Seizure events and confusional states – how to proceed? An afternoon event on “Neuro Emergencies” at the Inselspital in Bern focused, among other things, on the clinical distinction between psychogenic and epileptic seizures. The two types of seizures have…
View Post 2 min This content is machine translated Cancer and stroke Retrospective study offers little hope for stroke patients with cancer The aim of a new study was to find out how often and in what way recurrent thromboembolic events present after acute ischemic stroke. This only involved stroke patients who…
View Post 2 min This content is machine translated Acute coronary syndrome What medications can be used in everyday practice? In the first-line treatment of acute coronary syndrome (ACS), ticagrelor and prasugrel have been shown to be effective, according to PD Jan Steffel, MD, Zurich.
